Inventor · disambiguated record
Susanne Werner-Simon
Also filed as: WERNER-SIMON SUSANNE
8 granted patents·3 pending applications·3 citations·filing 2016–2025
76Inventor score
Files withHEIDELBERG PHARMA RES GMBH11
Top patents by PatentIndex Score
11 records- 0175US11420971B2Method for synthesizing amanitinsHEIDELBERG PHARMA RES GMBH·Filed 2018·Granted Aug 23, 2022·1 cites·8 claims
- 0275US10961277B2Method for synthesizing amanitinsHEIDELBERG PHARMA RES GMBH·Filed 2018·Granted Mar 30, 2021·1 cites·9 claims
- 0374US12201693B2Amanitin conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2023·Granted Jan 21, 2025·0 cites·5 claims
- 0473US11590238B2Amanitin conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2017·Granted Feb 28, 2023·1 cites·6 claims
- 0572US2025009901A1Composition comprising a combination of immune checkpoint inhibitor and antibody-amatoxin conjugate for use in cancer therapyHEIDELBERG PHARMA RES GMBH·Filed 2024·Application pending·0 cites
- 0670US11926631B2Method of treating cancer using amanitin derivativesHEIDELBERG PHARMA RES GMBH·Filed 2022·Granted Mar 12, 2024·0 cites·4 claims
- 0765US12378196B2Synthesis of (S)-6-hydroxytryptophan and derivatives thereofHEIDELBERG PHARMA RES GMBH·Filed 2019·Granted Aug 5, 2025·0 cites·16 claims
- 0864US11702451B2Method for synthesizing amanitinsHEIDELBERG PHARMA RES GMBH·Filed 2021·Granted Jul 18, 2023·0 cites·20 claims
- 0961US2022133902A1Composition Comprising a Combination of Immune Checkpoint Inhibitor and Antibody-Amatoxin Conjugate for Use in Cancer TherapyHEIDELBERG PHARMA RES GMBH·Filed 2021·Application pending·0 cites
- 1055US2025179018A1Synthesis of (s)-6-hydroxytryptophan and derivatives thereofHEIDELBERG PHARMA RES GMBH·Filed 2025·Application pending·0 cites
- 1149US10723766B2Derivatives of gamma-amanitinHEIDELBERG PHARMA RES GMBH·Filed 2016·Granted Jul 28, 2020·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Susanne Werner-Simon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →